Dr. Reddy’s picks up Teva portfolio | Chemical & Engineering News
Volume 94 Issue 25 | p. 13 | Concentrates
Issue Date: June 20, 2016

Dr. Reddy’s picks up Teva portfolio

Department: Business
Keywords: pharmaceuticals, generic drugs, divestment

The Indian generic drugmaker Dr. Reddy’s Laboratories has agreed to acquire eight Abbreviated New Drug Applications from Israel’s Teva Pharmaceutical Industries for $350 million. Teva is divesting the products as a precondition to closing on its acquisition of Allergan’s generic drugs business. The combined annual U.S. sales of the branded versions of the drugs involved are about $3.5 billion, the firms say.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment